2026. Interleukin-39 as a Potential Biomarker of Diabetic Neuropathy: A Case–Control Study with ROC Curve Analysis. Chemical Interactions. 3, 1 (Feb. 2026). DOI:https://doi.org/10.64354/n44khb87.